AR116481A1 - Biomaterial que comprende células madre derivadas de tejido adiposo y gelatina y método para producir el mismo - Google Patents
Biomaterial que comprende células madre derivadas de tejido adiposo y gelatina y método para producir el mismoInfo
- Publication number
- AR116481A1 AR116481A1 ARP190102693A ARP190102693A AR116481A1 AR 116481 A1 AR116481 A1 AR 116481A1 AR P190102693 A ARP190102693 A AR P190102693A AR P190102693 A ARP190102693 A AR P190102693A AR 116481 A1 AR116481 A1 AR 116481A1
- Authority
- AR
- Argentina
- Prior art keywords
- gelatin
- stem cells
- adipose tissue
- produce
- same
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0697—Artificial constructs associating cells of different lineages, e.g. tissue equivalents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
- A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
- A61L27/3834—Cells able to produce different cell types, e.g. hematopoietic stem cells, mesenchymal stem cells, marrow stromal cells, embryonic stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/35—Fat tissue; Adipocytes; Stromal cells; Connective tissues
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
- A61L27/222—Gelatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
- A61L27/3633—Extracellular matrix [ECM]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
- A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0654—Osteocytes, Osteoblasts, Odontocytes; Bones, Teeth
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0662—Stem cells
- C12N5/0667—Adipose-derived stem cells [ADSC]; Adipose stromal stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2400/00—Materials characterised by their function or physical properties
- A61L2400/12—Nanosized materials, e.g. nanofibres, nanoparticles, nanowires, nanotubes; Nanostructured surfaces
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/34—Materials or treatment for tissue regeneration for soft tissue reconstruction
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
- C12N2506/13—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from connective tissue cells, from mesenchymal cells
- C12N2506/1346—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from connective tissue cells, from mesenchymal cells from mesenchymal stem cells
- C12N2506/1384—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from connective tissue cells, from mesenchymal cells from mesenchymal stem cells from adipose-derived stem cells [ADSC], from adipose stromal stem cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2513/00—3D culture
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/50—Proteins
- C12N2533/54—Collagen; Gelatin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/90—Substrates of biological origin, e.g. extracellular matrix, decellularised tissue
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Cell Biology (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Developmental Biology & Embryology (AREA)
- Wood Science & Technology (AREA)
- Dermatology (AREA)
- Genetics & Genomics (AREA)
- Transplantation (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Microbiology (AREA)
- Urology & Nephrology (AREA)
- Botany (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Virology (AREA)
- Biophysics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- General Chemical & Material Sciences (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Materials For Medical Uses (AREA)
Abstract
La presente se refiere a un biomaterial que comprende células madre derivadas de tejido adiposo (ASC), una matriz extracelular y gelatina. La presente también se refiere a métodos para producir el biomaterial y usos del mismo.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201862734064P | 2018-09-20 | 2018-09-20 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR116481A1 true AR116481A1 (es) | 2021-05-12 |
Family
ID=68062936
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP190102693A AR116481A1 (es) | 2018-09-20 | 2019-09-23 | Biomaterial que comprende células madre derivadas de tejido adiposo y gelatina y método para producir el mismo |
Country Status (13)
Country | Link |
---|---|
US (1) | US20210322644A1 (es) |
EP (1) | EP3853350A1 (es) |
JP (1) | JP2022501118A (es) |
KR (1) | KR20210063324A (es) |
CN (1) | CN112823205A (es) |
AR (1) | AR116481A1 (es) |
AU (1) | AU2019342877A1 (es) |
BR (1) | BR112021005285A2 (es) |
CA (1) | CA3112846A1 (es) |
IL (1) | IL281179B1 (es) |
MX (1) | MX2021003219A (es) |
SG (1) | SG11202101902QA (es) |
WO (1) | WO2020058511A1 (es) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2023504013A (ja) | 2019-11-29 | 2023-02-01 | ノヴァディップ バイオサイエンシズ | 組織障害の予防および治療のための生体材料 |
WO2021105407A1 (en) | 2019-11-29 | 2021-06-03 | Novadip Biosciences | miRNA-BASED PHARMACEUTICAL COMPOSITIONS AND USES THEREOF FOR THE PREVENTION AND THE TREATMENT OF TISSUE DISORDERS |
EP4005577A1 (en) | 2020-11-26 | 2022-06-01 | Novadip Biosciences | Cellular and/or extracellular extracts for preventing and/or treating cancer and/or inflammation |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AUPR289601A0 (en) * | 2001-02-05 | 2001-03-01 | Commonwealth Scientific And Industrial Research Organisation | Method of tissue repair |
JP2009513207A (ja) * | 2005-10-27 | 2009-04-02 | コロプラスト アクティーゼルスカブ | Ecm材料を伴う生分解性足場 |
EP3090764A1 (en) * | 2015-05-08 | 2016-11-09 | Université Catholique De Louvain | Compositions comprising mesenchymal stem cells and uses thereof |
CN105779383A (zh) * | 2016-03-12 | 2016-07-20 | 上海盛缘生物技术有限公司 | 一种脂肪干细胞-水凝胶三维培养体系的制备方法及应用 |
CN106727706A (zh) * | 2016-12-26 | 2017-05-31 | 湖南新起源医疗技术有限公司 | 一种用于皮肤损伤修复的细胞制剂的制备方法 |
CN108187142A (zh) * | 2018-01-31 | 2018-06-22 | 广州沙艾生物科技有限公司 | 一种干细胞在生物组织修复中的应用 |
-
2019
- 2019-09-20 EP EP19773799.2A patent/EP3853350A1/en active Pending
- 2019-09-20 SG SG11202101902QA patent/SG11202101902QA/en unknown
- 2019-09-20 KR KR1020217006711A patent/KR20210063324A/ko unknown
- 2019-09-20 MX MX2021003219A patent/MX2021003219A/es unknown
- 2019-09-20 WO PCT/EP2019/075413 patent/WO2020058511A1/en active Application Filing
- 2019-09-20 CA CA3112846A patent/CA3112846A1/en active Pending
- 2019-09-20 IL IL281179A patent/IL281179B1/en unknown
- 2019-09-20 CN CN201980061659.9A patent/CN112823205A/zh active Pending
- 2019-09-20 JP JP2021515540A patent/JP2022501118A/ja active Pending
- 2019-09-20 BR BR112021005285-2A patent/BR112021005285A2/pt unknown
- 2019-09-20 US US17/273,143 patent/US20210322644A1/en active Pending
- 2019-09-20 AU AU2019342877A patent/AU2019342877A1/en active Pending
- 2019-09-23 AR ARP190102693A patent/AR116481A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
JP2022501118A (ja) | 2022-01-06 |
IL281179B1 (en) | 2024-06-01 |
WO2020058511A1 (en) | 2020-03-26 |
KR20210063324A (ko) | 2021-06-01 |
IL281179A (en) | 2021-04-29 |
AU2019342877A1 (en) | 2021-03-11 |
EP3853350A1 (en) | 2021-07-28 |
BR112021005285A2 (pt) | 2021-06-22 |
MX2021003219A (es) | 2021-07-16 |
CA3112846A1 (en) | 2020-03-26 |
US20210322644A1 (en) | 2021-10-21 |
CN112823205A (zh) | 2021-05-18 |
SG11202101902QA (en) | 2021-04-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NI201600092A (es) | Identificación del flujo del tiempo activo blanco en el reconocimiento del twt | |
AR116481A1 (es) | Biomaterial que comprende células madre derivadas de tejido adiposo y gelatina y método para producir el mismo | |
CO2021008568A2 (es) | Anticuerpos que se unen a cd3 | |
CL2019002793A1 (es) | Composición para producir tagatosa y procedimiento de producción de tagatosa usando la misma. | |
CO2020012583A2 (es) | Métodos para tratar las enfermedades asociadas al vph | |
AR111184A1 (es) | Poliamidas y métodos para producir los mismos | |
BR112013027307A2 (pt) | método para tratar uma matriz de tecido; matriz de tecido acelular | |
BR112017009806A2 (pt) | sistema e método para gerar informações de nível de estresse e de nível de resiliência de estresse para um indivíduo | |
AR114979A1 (es) | Espuma de poliuretano híbrida y métodos de fabricación | |
BR112015017174A2 (pt) | preparação de enxertos de nervo de tecido manipulado com matriz extracelular modificada para reparo de lesão de nervo periférico | |
CL2019000318A1 (es) | Método para producir un l-aminoácido tal como l-lisina. | |
BR112022001207A2 (pt) | Método de obtenção de mitocôndrias de células e mitocôndrias obtidas | |
BR112019025372A2 (pt) | Suplemento de ração animal, composição de ração animal, usos de um suplemento, métodos para produzir um suplemento de ração animal e para produzir uma composição de ração animal | |
CO2017000367A2 (es) | Producción microbiana de dioles grasos | |
BR112018011250A2 (pt) | método para fabricar um implante de tecido mole, e sistema | |
CA2911567C (en) | Implant and method of producing an implant by decellularising an tissue by perfusion under negative pressure | |
AR112587A1 (es) | Psicosa-6-fosfato fosfatasa, composición para producir d-psicosa que comprende la enzima y métodos para producir d-psicosa utilizando la enzima | |
BR112017020513A2 (pt) | método de produção de peixe para transplante, peixe para transplante, método de produção de espécie híbrida de peixe e espécie híbrida de peixe | |
BR112018070293A2 (pt) | diferenciação de células-tronco pluripotentes em células do endoderma intestinal do intestino médio | |
CL2018000111A1 (es) | Microorganismos para la producción de putrescina u ornitina y procedimiento para la producción de putrescina u ornitina usando los mismos | |
AR114088A1 (es) | Un microorganismo del género corynebacterium productor de l-aminoácidos y un método para producir l-aminoácidos usando el mismo | |
AR113122A1 (es) | Método para mejorar la estabilidad en almacenamiento y aptitud biológica de esporas fúngicas | |
BR112021024043A2 (pt) | Implante mamário biológico | |
BR112017001696A2 (pt) | composições de célula-tronco e métodos de produção de células-tronco para aplicações terapêuticas | |
BR112016027341A2 (pt) | micro-organismo do gênero escherichia que tem um nível de atp intracelular aumentado e método para produzir l-aminoácidos |